Gen-Probe Incorporated
Marlborough, MA Part of Hologic, Inc.
- UEI
- QNXWLAJDL4J3
- CAGE
- 0BDV3
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Grifols SA, ranks #93 in PSC 6550
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Hologic, Inc. · Marlborough, MA
WHWJBKU5SX73
-
- G8BMNK47Y8H4
- Immucor GTI Diagnostics Inc. CZJRW6YRLUB4
-
-
Parent
Hologic, Inc. · Marlborough, MA
WHWJBKU5SX73
- SAM.gov registration date
- Physical address
- 250 Campus Dr, Marlborough, MA 01752, USA
- Website
- hologic.com
- Founded
- 1985
- Employees
- 5K-10K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $25,220 |
| FY2025 | $129,435 |
| FY2024 | -$704,956 |
| FY2023 | $15,967,493 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Navy | $24,500 | |
| 2 | Defense Health Agency | $720 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Specimen transfer kit | Defense Health Agency | $720 | |
| Supplies and consumables for HIV-1 assays | Defense Health Agency | $397,568 | |
| Panther fusion standard service | Defense Health Agency | $56,000 | |
| PRD-03565, aptima HIV-1 quant DX assay | Defense Health Agency | $186,784 | |
| Aptima HIV-1, PRD-03565 | Defense Health Agency | $112,672 |
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prostate cancer DNA research initiative | Department of the Army | $3,590,000 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Meridian Bioscience Inc. | Cincinnati, OH | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Abbott Molecular Inc. | Des Plaines, IL | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Luminex Corp | Austin, TX | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Roche Diagnostics Corporation | Indianapolis, IN | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Diasorin Inc. | Stillwater, MN | 325413 In-Vitro Diagnostic Substance Manufacturing |
About the company
Gen-Probe Incorporated, a division of Hologic, Inc., supplies molecular diagnostic test kits, assays, reagents, analyzer systems, and related consumables to Department of Defense and Veterans Affairs medical facilities as a prime contractor on full-and-open federal contracts, with no set-aside posture across its recent footprint. The Marlborough, Massachusetts-based company operates through its Gen-Probe Sales & Service, Inc. division and holds two named subsidiaries: Gen-Probe Prodesse, Inc. and Immucor GTI Diagnostics Inc.
Gen-Probe's federal customer base is heavily concentrated in military and defense medical supply, with Department of the Army Medical Command (228 awards, $176.4 million combined potential value) and the Defense Health Agency (58 awards, $44 million combined potential value) anchoring the portfolio. Department of the Navy Bureau of Medicine and Surgery placed 140 awards valued at $43.6 million combined. The Defense Logistics Agency Troop Support Medical accounts for the highest award count at 703 awards but carries minimal dollar value ($733 thousand combined potential value), indicating high-volume, low-value transactions characteristic of supply-chain replenishment orders. The top five customer agencies by potential value cover 90% of the combined value across 1,830 awards.
Gen-Probe's capability portfolio centers on in-vitro diagnostic substances and molecular analyzer systems. Recent representative work includes supplying APTIMA SARS-CoV-2 ASSAY test kits under a $15 million single-award Indefinite Delivery Contract with the Defense Health Agency (awarded January 2022, ceiling $14,999,999.99, ultimate completion June 2022) with multiple firm-fixed-price delivery orders ranging from $320,542.72 to $552,691.20; a $543,750 delivery order with DHA for molecular analyzer systems, reagents, and associated supplies for Madigan Army Medical Center (awarded October 2022); a $1.7 million delivery order with VA Veterans Integrated Service Network 12 for PANTHER reagents and consumables (awarded June 2022); and recurring BPA calls for APTIMA HIV-1, hepatitis C, and chlamydia/gonorrhea assays to Army Medical Command facilities, Navy Bureau of Medicine and Surgery sites, and VA medical centers.
Gen-Probe sits on multiple IDICs, each generating high call volumes. Indefinite Delivery Contract SPE2DH17D5015 has generated 406 task orders (combined potential value $132 thousand), SPE2DH15D5006 has generated 121 task orders ($51 thousand), and SPE2DH16D5009 has generated 111 task orders ($45 thousand). These vehicles reflect the Defense Logistics Agency Troop Support Medical's high-frequency ordering pattern for supply-chain replenishment. The vendor also places work against Blanket Purchase Agreements, including W91YTZ15A0011 with 37 task orders ($1.5 million combined potential value).
Activity has declined substantially from 42 awards in 2021 to 27 in 2022, 4 in 2023, 2 in 2024, and 1 in 2025, suggesting a contraction in federal footprint over the past three years. Only two awards carry ultimate completion dates within the next twenty-four months, with combined potential value of $242 thousand, indicating minimal recompete exposure in that window. The vendor operates 100% as a prime contractor with no subcontract activity in the source data.
Gen-Probe's NAICS and PSC profile reflects its core capability: In-Vitro Diagnostic Substance Manufacturing (496 awards) and Surgical Appliance and Supplies Manufacturing (438 awards) dominate NAICS distribution, while Laboratory Equipment and Supplies (1,001 awards) and In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (446 awards) define the PSC footprint. The portfolio's dollar concentration — 66% of combined potential value obligated across all awards — indicates that Gen-Probe delivers routine consumables and reagent refills rather than major capital equipment or systems integration work.
Quick answers
Is Gen-Probe Incorporated registered in SAM.gov?
Yes. Gen-Probe Incorporated's SAM.gov registration is active through September 1, 2027.
How much has Gen-Probe Incorporated received in federal contracts?
Federal contracts obligated $129,435 to Gen-Probe Incorporated in fiscal year 2025 and $15,417,192 in fiscal years 2023 through 2027.
How does Gen-Probe Incorporated rank among federal contractors?
Gen-Probe Incorporated's parent company, Grifols SA, ranked #93 in PSC 6550 in FY2025.
What is Gen-Probe Incorporated's most recent federal award?
Gen-Probe Incorporated's most recent federal contract award is Specimen transfer kit (HT940626PE009), from Defense Health Agency, on November 21, 2025.
On GovTribe
See Gen-Probe Incorporated's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors